The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Great interview. Mosaic moved quickly to seal a deal with Rainbow. So now there is the US government, through TechMet and a massive fertiliser company, who both have a vested interest in the success of this enterprise.
So what does Mosaic get out of the deal? There is potential profits from the rare earth sales, environmental clean up of a massive waste stack, sales of gypsum, almost at no added costs (depending on the final agreement) and exclusivity on the process, within Brazil. What does Rainbow get out of it? Sales of gypsum and Rare earths, access to another larger raw material, on site acid supply, infrastructure and logistics and a reduced geopolitical risk. There is the price of taking samples, providing a PEA and other feasibility steps to overcome.
Even George was surprised at the speed of Mosaic accepting the MOU. This can either be based on the need for exclusivity or their desire to turn their waste into a cash generator or possibly both. Whatever the rational it points to the credibility of George and his team and their process and partners.
I have never been as excited by a investment as this and I appreciate that there are hurdle to overcome but the risk to reward offering is immense.
Watch the whole but the critical elements are post 8 minutes 20 seconds.
Lovelyboy,
Belated thank you for pointing out the video. I thought it was text only. You, cadellin and SP were correct 50:50 was mentioned.
SP,
Are you sure it will be a 50:50 JV? I have scanned through the press, the RNS and the interview and can't see this referenced.
The greater element to consider is that operating phosphate plants already have the infrastructure and acid plants that Phalaborwa had to rebuild and supply.
SmartPunter,
This perfectly ties into the western need to install SMR (small modular reactor)units, to give national grids rigidity and offer "Carbon Free" electricity production when renewable options are unable to deliver. The future, like it or not, is renewables supported by SMR's. Both bases are covered by K-Tech and their partners.
An interesting and balanced article. Good business with issues, focused on ROE. They made AUD200k profit on 150,000 tonnes sold. In other words is there likely to be a profit on the revised 120,000 tonnes target? It also brings into question BM break even figure. Can BM control costs in 2023 to make a profit?
https://simplywall.st/stocks/gb/materials/aim-hmi/harvest-minerals-shares/news/declining-stock-and-decent-financials-is-the-market-wrong-ab-772/amp
Al4x,
Yes I too am a boomer but there are a variety of cruise line offerings, to cater for most age groups. If you are thinking of a younger age group look at Carnival, Royal Caribbean, MSC and Norwegian. We thought P&O, out of school holidays, was too old even for us and were so pleased with Celebrity and Princess. They were a breath of fresh air.
Look at the reviews and be open minded. Also chose a holiday region that appeals to you and your interests. Realise that the ship is not a prison and you can get off to explore great parts of the world. Would say look at the CCL cruise lines for onboard spending, as an influence on your decision.
The SP keeps rising and hits £13 for the first time in 1.25 years.
Fairy 1, It would be rude not to.
RCL also offer a similar deal but at an investment of £8250, that is much more of a leap of faith. Do like Celebrity Cruises though but the share price is too rich for me.
Fairy 1,
Here is the Carnival link:
https://www.carnivalcorp.com/static-files/50351a91-4dc0-4f6b-bfec-684647e6129f
You have to own 100 shares and then notify your booking company or the Carnival cruise line you are booked on, with proof of shares. You should have a transaction note and I tend to show them my dividend payments (old days) that I still own the shares. I will, in the future send a screenshot of my investment and if necessary get HL to confirm proof of ownership.
Anon2, As good a reason as any to invest.
Having sold out at £1200 during the pandemic, at a SP loss of £2300. Saying that I earned about £2500 of onboard spending and possibly £500+ in dividends. Purchased back in, in December at £727 (gross) and have or about to receive £332 onboard credit. The rise in SP is a "nice to have" benefit.
Carnival have a range of products to suit all tastes. Clearly the market is coming back and apart from the debt, what is there not to like? Banks would not have loaned Carnival the debt provision without conservatively assessing their ability to pay it back. With Carnival beating sales expectations I can only see this SP moving in one direction. All you need to do is look at is RCL for a direct comparison.
You have to love hindsight. I am in this for the onboard credit and so have no emotion in it, nor to be fair a lot of money at risk.
We fell out of favour with P&O, after how they treated my father, pre-pandemic. Been on a Princess cruise through the Panama Canal which I can recommend to anyone. On the back of this we have booked a circumnavigation of Australia, with Princess. Great service, magnificent cruise and a big enough difference to the P&O to justify the adventure.
ReeTech, Pensana share holders have gone through a lot of pain to achieve their 25% rise today. Even taking their daily rise, over the last month Pensana shares are down 48% and Rainbow is down 17%. Neither is good but it is the scale.
:)
Chique, timing of a statement is everything. I don't know why it has been driven up. Can only think inside dealing.
It is not so much the company which has generally performed admirably, it is where the commodity prices are presently heading. Iron Ore, copper and platinum prices are all down. The great news is Anglo have a fantastic source of Iron Ore at Minas Rio that is the one of the best , if not actually the best, source for "green" steel production, through DRI.
GSK had loaded £10.7bn of debt onto Haleon bringing the figure much closer to the Unilever price. The OTC business was always the cash cow for GSK and had carried the business for a long time. My wife and I decided (hindsight is a powerful tool), after the demerger, to significantly increase our shareholding in Haleon, as it was no longer saddled with the previously underperforming GSK. We knew that the initial priority for the company was to pay off this debt which they are doing. The growth projections are good and management are moving the business in the right direction.
Before a pile of trolls pile in, I still am still invested in GSK and am seeing the green shoots of R&D starting to emerge. No longer have they got the safety net of Haleon and so their management now have to perform.
"here" even!
Chique,
The problem maybe the trust the investors have with BM and the inconsistencies with data presentation. Then there is the lack of due diligence on acquisitions that are at best deemed questionable, some on hear are a bit more forthright on this subject. This is our money, our investment and extreme care should be taken on looking after it.
The contrast between this RNS and the investor feelings on the Pensana board is stark. Pensana apparently have a cash shortage and their share price is down 30% today. Trust in experienced management is key to any investment.